dMD-002 for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 May 2026: Trial registered, NCT07564102

The trials

NCT07564102: dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy

State
Not started
Phase
Phase 1 and Phase 2
People
30 planned
Started
1 Aug 2026
Primary completion
30 Sep 2027
Arms
Treatment group
Results
None posted
  1. 4 May 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.